A detailed history of Dn B Asset Management As transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Dn B Asset Management As holds 160,302 shares of TEVA stock, worth $2.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
160,302
Previous 146,301 9.57%
Holding current value
$2.95 Million
Previous $2.06 Million 26.16%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$12.78 - $17.4 $178,932 - $243,617
14,001 Added 9.57%
160,302 $2.6 Million
Q1 2024

Apr 12, 2024

SELL
$10.67 - $14.43 $19,216 - $25,988
-1,801 Reduced 1.22%
146,301 $2.06 Million
Q3 2023

Oct 13, 2023

BUY
$7.48 - $10.7 $27,331 - $39,097
3,654 Added 2.53%
148,102 $1.51 Million
Q2 2023

Jul 10, 2023

BUY
$7.2 - $9.47 $1.04 Million - $1.37 Million
144,448 New
144,448 $1.09 Million
Q1 2023

Apr 20, 2023

SELL
$8.36 - $11.37 $23,366 - $31,779
-2,795 Reduced 1.9%
144,448 $1.28 Million
Q4 2022

Jan 12, 2023

SELL
$7.95 - $9.48 $70,755 - $84,372
-8,900 Reduced 5.7%
147,243 $1.34 Billion
Q3 2022

Oct 11, 2022

BUY
$6.86 - $11.95 $162,609 - $283,262
23,704 Added 17.9%
156,143 $1.26 Million
Q1 2022

Apr 08, 2022

SELL
$7.33 - $9.39 $16,272 - $20,845
-2,220 Reduced 1.65%
132,439 $1.24 Million
Q4 2021

Jan 12, 2022

BUY
$7.9 - $10.19 $56,516 - $72,899
7,154 Added 5.61%
134,659 $1.08 Million
Q3 2021

Oct 15, 2021

BUY
$8.38 - $10.18 $47,372 - $57,547
5,653 Added 4.64%
127,505 $1.24 Million
Q1 2021

Apr 15, 2021

BUY
$10.34 - $12.81 $216,426 - $268,126
20,931 Added 20.74%
121,852 $1.41 Million
Q4 2020

Jan 19, 2021

BUY
$8.61 - $11.04 $175,247 - $224,708
20,354 Added 25.26%
100,921 $973,000
Q3 2020

Oct 14, 2020

BUY
$8.57 - $12.69 $43,569 - $64,515
5,084 Added 6.74%
80,567 $725,000
Q1 2020

Apr 17, 2020

SELL
$6.69 - $13.45 $149,267 - $300,096
-22,312 Reduced 22.82%
75,483 $677,000
Q4 2019

Jan 13, 2020

BUY
$6.53 - $10.72 $81,840 - $134,353
12,533 Added 14.7%
97,795 $958,000
Q2 2019

Jul 08, 2019

BUY
$8.12 - $15.72 $68,037 - $131,717
8,379 Added 10.9%
85,262 $0
Q1 2019

Apr 11, 2019

SELL
$15.58 - $20.01 $82,729 - $106,253
-5,310 Reduced 6.46%
76,883 $0
Q4 2018

Jan 15, 2019

BUY
$14.59 - $23.84 $46,527 - $76,025
3,189 Added 4.04%
82,193 $1.27 Million
Q3 2018

Oct 10, 2018

BUY
$21.06 - $25.65 $27,462 - $33,447
1,304 Added 1.68%
79,004 $0
Q2 2018

Jul 06, 2018

BUY
$16.77 - $24.71 $155,961 - $229,803
9,300 Added 13.6%
77,700 $0
Q1 2018

Apr 11, 2018

BUY
$16.68 - $22.07 $126,768 - $167,732
7,600 Added 12.5%
68,400 $0
Q3 2017

Oct 11, 2017

BUY
$15.41 - $32.17 $936,928 - $1.96 Million
60,800
60,800 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.